Tumor-Derived Autophagosomes (DRibbles) Induce B Cell Activation in a TLR2-MyD88 Dependent Manner

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Weixia ^a   Zhou, Meng ^a   Ren, Hongyan ^a,b   Hu, Hong Ming ^b,c   Lu, Liwei ^d   Cao, Meng ^a   Wang, Li Xin ^a,b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b Nanjing Second Hospital   (China)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOPHAGOSOME; B LYMPHOCYTE ACTIVATION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LYMPHOCYTE SUBPOPULATION; MOLECULAR MODEL; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE; TUMOR MODEL;

MURINAE; MUS;

EID: 84872256620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053564     Document Type: Article

References (46)

1. Abeliovich H, Dunn WAJ, Kim J, Klionsky DJ, (2000) Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol 151: 1025-1034.
2. Li YH, Wang LX, Pang P, Twitty C, Fox BA, et al. (2009) Cross presentation of tumor associated antigens through tumor-derived autophagosomes. Autophagy 5: 576-577.
3. Li Y, Wang LX, Yang G, Hao F, Urba WJ, et al. (2008) Efficient Cross-presentation Depends on Autophagy in Tumor Cells. Cancer Res 68: 6889-6895.
4. Li YH, Wang LX, Pang P, Cui Z, Aung S, et al. (2011) Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res 17(00): 1-11.
5. Twitty CG, Jensen SM, Hu HM, Fox BA, (2011) Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism. Clin Cancer Res 17: 6467-6481.
6. Carrasco YR, Batista FD, (2006) B cell recognition of membrane-bound antigen: an exquisite way of sensing ligands. Curr Opin Immunol 18: 286-291.
7. Depoil D, Fleire S, Treanor BL, Weber M, Harwood NE, et al. (2008) CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 9: 63-72.
8. Barr TA, Brown S, Ryan G, Zhao J, Gray D, (2007) TLR-mediated stimulation of APCs: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37: 3040-3053.
9. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, et al. (2007) TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 178: 7779-7786.
10. Gray D, Gray M, Barr T, (2007) Innate responses of B cells. Eur J Immunol 37: 3304-3310.
11. de Wit J, Souwer Y, Jorritsma T, Klaasse Bos H, ten Brinke A, et al. (2010) Antigen-specific B cells reactivate an effective cytotoxic T cell response against phagocytosed Salmonella through cross-presentation. PLoS One 5: e13016.
12. Ke Y, Kapp JA, (1996) Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J Exp Med 184: 1179-1184.
13. Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, et al. (2003) CD40-dependent and-independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur J Immunol 33: 1576-1585.
14. Lu H, Crawford RB, Kaplan BL, Kaminski NE, (2011) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicology and Applied Pharmacology 255: 251-260.
15. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, et al. (2007) B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol 179: 4857-4866.
16. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, et al. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1: 475-482.
17. Skok J, Poudrier J, Gray D, (1999) Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J Immunol 163: 4284-4291.
18. Barr TA, Brown S, Ryan G, Zhao J, Gray D, (2007) TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37: 3040-3053.
19. Serre K, Machy P, Grivel JC, Jolly G, Brun N, et al. (1998) Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells. J Immunol 161: 6059-6067.
20. Neller MA, Lopez JA, Schmidt CW, (2008) Antigens for cancer immunotherapy. Semin Immunol 20: 286-295.
21. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ, (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176: 154-170.
22. O'Garra A, Stapleton G, Dhar V, Pearce M, Schumacher J, et al. (1990) Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2: 821-832.
23. Agrawal S, Gollapudi S, Su H, Gupta S, (2011) Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol 31: 472-478.
24. Pistoia V, (1997) Production of cytokines by human B cells in health and disease. Immunol Today 18: 343-350.
25. Airoldi I, Guglielmino R, Ghiotto F, Corcione A, Facchetti P, et al. (2001) Cytokine Gene Expression in Neoplastic B Cells from Human Mantle Cell, Follicular, and Marginal Zone Lymphomas and in Their Postulated Normal Counterparts. Cancer Res 61: 1285-1290.
26. Kouskoff V, Famiglietti S, Lacaud G, Lang P, Rider JE, et al. (1998) Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med 188: 1453-1464.
27. Kindler V, Matthes T, Jeannin P, Zubler RH, (1995) Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur J Immunol 25: 1239-1243.
28. Ohnishi E, Iwata T, Inouye S, Kurata T, Sairenji T, (1997) Interleukin-4 production in Epstein-Barr Virus transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. J Interferon Cytokine Res 17: 597-602.
29. Sartori A, Ma X, Gri G, Showe L, Benjamin D, et al. (1997) Interleukin-12: an immune-regulatory cytokine produced by B cells and antigen-presenting cells. Methods 11: 116-127.
30. Yang M, Sun L, Wang S, Ko KH, Xu H, et al. (2010) Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184(7): 3321-3325.
31. Bolhassani A, Rafati S, (2008) Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines 7: 1185-1199.
32. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, et al. (2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101: 3516-3521.
33. Takeda K, Akira S, (2004) TLR signaling pathways. Semin Immunol 16: 3-9.
34. Akira S, Takeda K, (2004) Toll-like receptor signaling. Nat Rev Immunol 4: 499-511.
35. Gosselin EJ, Tony HP, Parker DC, (1988) Characterization of antigen processing and presentation by resting B lymphocytes. J lmmunol 140: 1408-1413.
36. Singer DF, Linderman JJ, (1990) The Relationship between Antigen Concentration, Antigen Internalization, and Antigenic Complexes: Modeling Insights into Antigen Processing and Presentation. J Cell Biol 111: 55-68.
37. Wagle NM, Kim JH, Pierce SK, (1999) CD19 regulates B cell antigen receptor-mediated MHC class II antigen processing. Vaccine 18: 376-386.
38. Zhang P, Li W, Wang Y, Hou L, Xing Y, et al. (2007) Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis. Mol Immunol 44: 332-337.
39. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, et al. (2002) FcgammaRI- deficient mice show multiple alterations to infl{ligature}ammatory and immune responses. Immunity 16: 379-389.
40. Crampton SP, Voynova E, Bolland S, (2010) Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci 1183: 58-68.
41. Peng SL, (2005) Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17: 230-236.
42. Bekeredjian-Ding I, Jego G, (2009) Toll-like receptors-sentries in the B-cell response. Immunology 128: 311-323.
43. Rozková D, Novotná L, Pytlík R, Hochová I, Kozák T, et al. (2010) Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Int J Cancer 126: 1132-1143.
44. Grivel JC, Crook K, Leserman L, (1994) Endocytosis and presentation of liposome-associated antigens by B cells. Immunomethods 4: 223-238.
45. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, et al. (1996) Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol 156: 2809-2818.
46. Zhao F, Dou J, He XF, Wang J, Chu L, et al. (2010) Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Vaccine. 28(16): 2846-2852.